mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.6 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.6 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |